• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by Hexindai Inc.

    11/19/21 2:21:12 PM ET
    $HX
    Finance: Consumer Services
    Finance
    Get the next $HX alert in real time by email
    144 1 ea151012-144_webaolimited.htm FORM 144 Form 144
     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    OMB APPROVAL
    OMB Number 325-0101
    Expires: July 31, 2023
    Estimated average burden hours
    per response 1.00
    FORM 144  
    SEC USE ONLY
    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
    DOCUMENT SEQUENCE NO.
     
     

    ATTENTION:  Transmit for filing 3 copies of this form concurrently with either placing an order with a broker to execute sale or executing a sale directly with a market maker.

    CUSIP NUMBER
     
     
                                        WORK LOCATION
      1(a) NAME OF ISSUER     (b) IRS IDENT. NO.     (c) S.E.C. FILE NO.      
     

    Xiaobai Maimai Inc.

                   
     
     

    1(d) ADDRESS OF ISSUER

        STREET
        CITY     STATE     ZIP CODE     (e) TELEPHONE NO.  
      Room 515, Floor 5, Jia No. 92-4 to 24 Jianguo Road       AREA CODE NUMBER  
     

     

              Chaoyang District    

    Beijing

        100020       86     10 5370 9902  
     
                                                 
      2(a) NAME OF PERSON FOR WHOSE ACCOUNT THE SECURITIES ARE TO BE SOLD           (b) RELATIONSHIP
    TO ISSUER
        (c) ADDRESS (Street)     CITY     STATE     ZIP CODE  
      Webao Limited           None     12 / F, Santai building, 137-139 Connaught Road Central     Hong Kong              
     

     

                                             
     

    INSTRUCTION: The person filing this notice should contact the issuer to obtain the I.R.S. Identification Number and the S.E.C. File Number.

                                                               
     
                  SEC USE                                
      3(a)     (b)     ONLY     (c)     (d)     (e)     (f)     (g)  

     

    Title of the
    Class of
    Securities
    To Be Sold
        Name and Address of Each Broker
    Through Whom the Securities are
    to be Offered or Each Market Maker
    who is Acquiring the Securities
        Broker-Dealer
    File Number
        Number of
    Shares or Other
    Units To Be Sold
    (See instr. 3(c))
        Aggregate
    Market Value
    (See instr. 3(d))
        Number of Shares
    or Other Units
    Outstanding
    (See instr. 3(e))
        Approximate
    Date of Sale
    (See instr. 3(f))
    (MO. DAY YR.)
        Name of Each
    Securities
    Exchange
    (See instr. 3(g))
     
     

    Common

       

    Viewtrade Securities 7280 W Palmetto Park Rd. Boca Raton FL 33433

                8,000,000         25,120,000         23,827,148       11-15-2021     Nasdaq  
     

                                               
     
    INSTRUCTIONS:
     
    1. (a) Name of issuer
     
    (b) Issuer’s I.R.S. Identification Number
     
    (c) Issuer’s S.E.C. file number, if any
     
    (d) Issuer’s address, including zip code
     
    (e) Issuer’s telephone number, including area code
     
     
    2. (a) Name of person for whose account the securities are to be sold
     
    (b) Such person’s relationship to the issuer (e.g., officer, director, 10 percent stockholder, or member of immediate family of any of the foregoing)
     
    (c) Such person’s address, including zip code
     
    3. (a) Title of the class of securities to be sold
     
    (b) Name and address of each broker through whom the securities are intended to be sold
     
    (c) Number of shares or other units to be sold (if debt securities, give the aggregate face amount)
     
    (d) Aggregate market value of the securities to be sold as of a specified date within 10 days prior to the filing of this notice
     
    (e) Number of shares or other units of the class outstanding, or if debt securities the face amount thereof outstanding, as shown by the most recent report or statement published by the issuer
     
    (f) Approximate date on which the securities are to be sold
     
    (g) Name of each securities exchange, if any, on which the securities are intended to be sold
     

    Potential persons who are to respond to the collection of information contained in this form are not required
    to respond unless the form displays a currently valid OMB control number.

     

     

    TABLE I — SECURITIES TO BE SOLD

    Furnish the following information with respect to the acquisition of the securities to be sold
    and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    Title of
    the Class
        Date you
    Acquired
        Name of Acquisition Transaction     Name of Person From
    Whom Acquired
    (If gift, also give date donor acquired)
        Amount of
    Securities Acquired
        Date of Payment     Nature of Payment
    Common     7/2/21     purchase     Hexin Holding Limited     10,660,266     2/7/21     Wire
     
    INSTRUCTIONS:   If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.
     
     

    TABLE II — SECURITIES SOLD DURING THE PAST 3 MONTHS

    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    Name and Address of the Seller     Title of Securities Sold     Date of Sale     Amount of
    Securities Sold
        Gross Proceeds
    None                
     

    Remarks:

     

     

     

    INSTRUCTIONS:

    See the definition of “person” in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

    Nov.11, 2021
     
    Date of Notice

     

     
    Date of Plan Adoption or Giving of Instruction,
    if Relying on Rule 10b5-1.

     

    /s/ Yunsong Li
     
    (Signature)

    The notice shall be signed by the person for whose account the securities are to be sold. At least one copy of the notice shall be manually signed.
    Any copies not manually signed shall bear typed or printed signatures.

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $HX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HX
    SEC Filings

    View All

    SEC Form 424B3 filed by Hexindai Inc.

    424B3 - Xiaobai Maimai Inc. (0001702318) (Filer)

    12/17/21 11:59:56 AM ET
    $HX
    Finance: Consumer Services
    Finance

    SEC Form 6-K filed by Hexindai Inc.

    6-K - Xiaobai Maimai Inc. (0001702318) (Filer)

    12/15/21 8:30:19 AM ET
    $HX
    Finance: Consumer Services
    Finance

    SEC Form 6-K filed by Hexindai Inc.

    6-K - Xiaobai Maimai Inc. (0001702318) (Filer)

    12/7/21 4:30:18 PM ET
    $HX
    Finance: Consumer Services
    Finance

    $HX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Akso Health Group Announces Effective Date of Name Change and Ticker Symbol Change

    BEIJING, Dec. 16, 2021 /PRNewswire/ -- Akso Health Group ("Akso Health", the "Company" or "We") (NASDAQ:AHG), formerly known as Xiaobai Maimai Inc., today announced that the Company will update its name and ticker symbol on the Nasdaq Stock Market, effective at the start of trading on December 16, 2021 (the "Effective Date"). On the Effective Date, the Company's ADS and ordinary shares will be quoted under the new name "Akso Health Group" which was previously approved by the Company's shareholders (the "Name Change"), and the Company's ticker symbol will be updated to "AHG". Ms. Yilin Wang, Chairwoman and Chief Executive Officer of Akso Health, commented, "We are excited to align our Nasdaq

    12/16/21 6:00:00 AM ET
    $HX
    Finance: Consumer Services
    Finance

    Akso Health Group Reports Unaudited Financial Results for First Half of Fiscal Year 2022

    BEIJING, Dec. 15, 2021 /PRNewswire/ -- Akso Health Group (NASDAQ:AHG) ("Akso Health", the "Company" or "we"), formerly known as Xiaobai Maimai Inc., a social e-commerce platform in China, today announced its unaudited condensed consolidated financial results for the six months ended September 30, 2021. The Company amended the ratio of ADS and ordinary shares from one (1) ADS representing one (1) ordinary share to one (1) ADS representing three (3) ordinary shares, effective as of August 24, 2020. Fiscal year refers to the 12-month period ended March 31. First Half of Fiscal Year 2022 Highlights Number of Average Monthly Mobile Active Users[1] for the six months ended September 30, 2021 was 8

    12/15/21 6:00:00 AM ET
    $HX
    Finance: Consumer Services
    Finance

    Xiaobai Maimai Announces the Results of Annual General Meeting and Name Change

    BEIJING, Dec. 3, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ:HX) ("Xiaobai Maimai" or the "Company"), today announced that it held the 2021 annual general meeting of shareholders (the "AGM") at the Meeting Room, Futian Shangri-La, 4088 Yi Tian Road, Futian District, Shenzhen 518408, People's Republic of China, at 10:00 a.m. (Beijing Time) on December 3, 2021. At the AGM, holders of 71,057,650 ordinary shares (including ordinary shares represented by the Company's American Depositary Shares), out of the 71,478,550 ordinary shares issued and outstanding, were present in person or by proxy, and therefore constituted a quorum of more than one-third of the ordinary shares outstanding and ent

    12/3/21 4:10:00 PM ET
    $HX
    Finance: Consumer Services
    Finance

    $HX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Hexindai Inc.

    SC 13D - Xiaobai Maimai Inc. (0001702318) (Subject)

    8/2/21 4:30:19 PM ET
    $HX
    Finance: Consumer Services
    Finance

    SEC Form SC 13G/A filed by Hexindai Inc. (Amendment)

    SC 13G/A - Xiaobai Maimai Inc. (0001702318) (Subject)

    7/23/21 4:30:21 PM ET
    $HX
    Finance: Consumer Services
    Finance

    SEC Form SC 13G/A filed

    SC 13G/A - Xiaobai Maimai Inc. (0001702318) (Subject)

    2/5/21 7:02:02 AM ET
    $HX
    Finance: Consumer Services
    Finance

    $HX
    Leadership Updates

    Live Leadership Updates

    View All

    Akso Health Group Reports Unaudited Financial Results for First Half of Fiscal Year 2022

    BEIJING, Dec. 15, 2021 /PRNewswire/ -- Akso Health Group (NASDAQ:AHG) ("Akso Health", the "Company" or "we"), formerly known as Xiaobai Maimai Inc., a social e-commerce platform in China, today announced its unaudited condensed consolidated financial results for the six months ended September 30, 2021. The Company amended the ratio of ADS and ordinary shares from one (1) ADS representing one (1) ordinary share to one (1) ADS representing three (3) ordinary shares, effective as of August 24, 2020. Fiscal year refers to the 12-month period ended March 31. First Half of Fiscal Year 2022 Highlights Number of Average Monthly Mobile Active Users[1] for the six months ended September 30, 2021 was 8

    12/15/21 6:00:00 AM ET
    $HX
    Finance: Consumer Services
    Finance

    Xiaobai Maimai Announces the Results of Annual General Meeting and Name Change

    BEIJING, Dec. 3, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ:HX) ("Xiaobai Maimai" or the "Company"), today announced that it held the 2021 annual general meeting of shareholders (the "AGM") at the Meeting Room, Futian Shangri-La, 4088 Yi Tian Road, Futian District, Shenzhen 518408, People's Republic of China, at 10:00 a.m. (Beijing Time) on December 3, 2021. At the AGM, holders of 71,057,650 ordinary shares (including ordinary shares represented by the Company's American Depositary Shares), out of the 71,478,550 ordinary shares issued and outstanding, were present in person or by proxy, and therefore constituted a quorum of more than one-third of the ordinary shares outstanding and ent

    12/3/21 4:10:00 PM ET
    $HX
    Finance: Consumer Services
    Finance

    Xiaobai Maimai Appoints Dr. Yingxian Liu as Medical Consultant for We Health Limited

    BEIJING, Oct. 22, 2021 /PRNewswire/ -- Xiaobai Maimai Inc. (NASDAQ:HX) ("Xiaobai Maimai," the "Company," or "we"), today announced the appointment of Dr. Yingxian Liu as the medical consultant to the Company. Dr. Liu will work closely with management to develop the Company's cancer therapy and radiation oncology business by the Company's wholly-owned subsidiary, We Health Limited. Dr. Liu received his medical degree from Sun Yat-sen University of Medical Sciences in Guangzhou, China. He completed his pathology residency at North Shore University Hospital in Manhasset, New York. Dr. Liu completed his hematopathology fellowship at Albert Einstein College of Medicine at Montefiore Medical Cente

    10/22/21 8:00:00 AM ET
    $HX
    Finance: Consumer Services
    Finance